[{"Assets_0_Q3_USD":229693000.0,"CommonStockSharesOutstanding_0_Q3_shares":30596.0,"NetIncomeLoss_1_Q3_USD":-31096000.0,"NetIncomeLoss_3_Q3_USD":-84178000.0,"StockholdersEquity_0_Q3_USD":205956000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]